Search "finasteride prostate cancer" and you'll find both "it prevents cancer" and "it causes aggressive cancer." Both come from the same landmark trial, interpreted at different points in time. Here's the current, evidence-based picture — plus the practical PSA issue that matters more day-to-day than either headline.
The origin: the Prostate Cancer Prevention Trial
A large, long-running trial tested whether finasteride reduces prostate cancer risk. The headline finding: men on finasteride had a lower overall incidence of prostate cancer.
The complication: the same trial initially showed a small increase in high-grade (more aggressive-looking) tumors among the finasteride group, which triggered years of concern. Later analysis suggested this was substantially a detection artifact — finasteride shrinks the prostate, making biopsies more likely to catch high-grade disease, rather than the drug causing more aggressive cancer. Long-term follow-up did not show a meaningful increase in prostate cancer deaths.
The PSA point that actually matters
Here's the practical issue that affects far more men than the cancer-risk debate: finasteride roughly halves your PSA reading.
PSA (prostate-specific antigen) is a key prostate cancer screening marker. If you're on finasteride and your doctor doesn't know it, a PSA that looks "normal" might actually be concerning — because the true value is about double what the test shows. A cancer could be missed.
What this means for you
| Question | Evidence-based answer |
|---|---|
| Does finasteride cause prostate cancer? | No — long-term data doesn't support increased mortality; overall incidence is lower |
| Does it prevent prostate cancer? | It reduces overall incidence, though it's not prescribed for prevention in hair-loss patients |
| Does it affect PSA screening? | Yes — halves PSA; your doctor must adjust interpretation |
Bottom line for men on finasteride for hair
If you're taking finasteride 1mg for hair loss, the prostate cancer data is reassuring rather than alarming. The actionable takeaway isn't fear — it's communication: make sure every provider who checks your PSA knows you're on finasteride, especially once you're 40+ and screening becomes routine.
Your options for getting treatment
If you've decided finasteride is right for you, these licensed telehealth providers can evaluate you and prescribe if appropriate. A provider — not this article — should make the call.
Care Bare Rx
Physician-owned platform with custom compounding — oral and topical finasteride, plus dutasteride, in one intake.
Note on compounded medications: Compounded finasteride is not FDA-approved. It is prepared by state-licensed compounding pharmacies and can be a legitimate option, but quality and consistency vary by pharmacy. Use an established provider with physician oversight.
Start a consultation → Paid link · Affiliate partnerStrut Health
Dermatologist-founded telehealth focused on hair loss, with hair-specific compounded topical formulas.
Note on compounded medications: Compounded finasteride is not FDA-approved. It is prepared by state-licensed compounding pharmacies and can be a legitimate option, but quality and consistency vary by pharmacy. Use an established provider with physician oversight.
Start a consultation → Paid link · Affiliate partnerSources
- Prostate Cancer Prevention Trial (PCPT) and long-term follow-up analyses.
- FDA Prescribing Information, Finasteride — PSA effects and prostate cancer data.
- Guidance on PSA interpretation in men taking 5-alpha-reductase inhibitors.
- Drugs.com. Finasteride prostate cancer risk information. 2026.